Advanced visualization company Imaging Biometrics has signed a global license agreement with the University of Pennsylvania (UPenn) for the development and commercialization of technology that may lead to an automated way to evaluate a tumor’s response to various treatment therapies.

The technology--which standardizes images on a voxel-by-voxel basis--was developed by Jay Udupa, PhD, at the UPenn School of Medicine. The Milwaukee-based Imaging Biometrics said that the technology will be incorporated into several branded products, including an image analysis toolkit currently under development, the IB Suite.